nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—PTGS2—lung cancer	0.242	1	CbGaD
Bumetanide—SLC22A7—Docetaxel—lung cancer	0.0628	0.2	CbGbCtD
Bumetanide—SLC22A11—Methotrexate—lung cancer	0.0476	0.152	CbGbCtD
Bumetanide—SLC22A7—Methotrexate—lung cancer	0.0454	0.144	CbGbCtD
Bumetanide—PTGS2—Cisplatin—lung cancer	0.0401	0.128	CbGbCtD
Bumetanide—PTGS2—Etoposide—lung cancer	0.0394	0.126	CbGbCtD
Bumetanide—SLCO1A2—Methotrexate—lung cancer	0.0318	0.101	CbGbCtD
Bumetanide—SLC22A8—Methotrexate—lung cancer	0.0277	0.0882	CbGbCtD
Bumetanide—SLC22A6—Methotrexate—lung cancer	0.0193	0.0614	CbGbCtD
Bumetanide—SLC12A4—mammary gland—lung cancer	0.00657	0.0846	CbGeAlD
Bumetanide—SLC12A2—mammary gland—lung cancer	0.00453	0.0584	CbGeAlD
Bumetanide—SLC12A4—respiratory system—lung cancer	0.00438	0.0564	CbGeAlD
Bumetanide—CFTR—respiratory system—lung cancer	0.00344	0.0443	CbGeAlD
Bumetanide—SLC12A2—respiratory system—lung cancer	0.00302	0.0389	CbGeAlD
Bumetanide—CA5B—mammary gland—lung cancer	0.00296	0.0382	CbGeAlD
Bumetanide—CFTR—epithelium—lung cancer	0.00287	0.037	CbGeAlD
Bumetanide—CFTR—bronchus—lung cancer	0.00283	0.0365	CbGeAlD
Bumetanide—CFTR—trachea—lung cancer	0.00254	0.0327	CbGeAlD
Bumetanide—SLC12A2—epithelium—lung cancer	0.00252	0.0325	CbGeAlD
Bumetanide—CA7—trachea—lung cancer	0.0025	0.0322	CbGeAlD
Bumetanide—SLC12A2—bronchus—lung cancer	0.00248	0.032	CbGeAlD
Bumetanide—SLC12A4—lung—lung cancer	0.00232	0.0299	CbGeAlD
Bumetanide—SLC12A2—trachea—lung cancer	0.00223	0.0288	CbGeAlD
Bumetanide—CA12—respiratory system—lung cancer	0.0022	0.0283	CbGeAlD
Bumetanide—SLC12A1—epithelium—lung cancer	0.00212	0.0273	CbGeAlD
Bumetanide—SLC12A2—cardiac atrium—lung cancer	0.0021	0.027	CbGeAlD
Bumetanide—CA14—cardiac atrium—lung cancer	0.00196	0.0252	CbGeAlD
Bumetanide—CFTR—lung—lung cancer	0.00183	0.0235	CbGeAlD
Bumetanide—SLC12A2—bone marrow—lung cancer	0.00177	0.0228	CbGeAlD
Bumetanide—CA12—trachea—lung cancer	0.00162	0.0209	CbGeAlD
Bumetanide—SLC12A2—lung—lung cancer	0.0016	0.0207	CbGeAlD
Bumetanide—SLC12A4—lymph node—lung cancer	0.00159	0.0205	CbGeAlD
Bumetanide—CA5B—cardiac atrium—lung cancer	0.00137	0.0177	CbGeAlD
Bumetanide—CA4—respiratory system—lung cancer	0.00136	0.0176	CbGeAlD
Bumetanide—CA12—lung—lung cancer	0.00117	0.0151	CbGeAlD
Bumetanide—SLC12A2—lymph node—lung cancer	0.0011	0.0141	CbGeAlD
Bumetanide—CA5B—lung—lung cancer	0.00105	0.0135	CbGeAlD
Bumetanide—CA4—trachea—lung cancer	0.00101	0.013	CbGeAlD
Bumetanide—CA4—cardiac atrium—lung cancer	0.000945	0.0122	CbGeAlD
Bumetanide—PTGS2—respiratory system—lung cancer	0.000834	0.0107	CbGeAlD
Bumetanide—SLCO1A2—lung—lung cancer	0.000817	0.0105	CbGeAlD
Bumetanide—CA4—bone marrow—lung cancer	0.000798	0.0103	CbGeAlD
Bumetanide—CA4—lung—lung cancer	0.000723	0.00932	CbGeAlD
Bumetanide—CA5B—lymph node—lung cancer	0.000716	0.00923	CbGeAlD
Bumetanide—PTGS2—epithelium—lung cancer	0.000697	0.00898	CbGeAlD
Bumetanide—PTGS2—bronchus—lung cancer	0.000686	0.00884	CbGeAlD
Bumetanide—PTGS2—trachea—lung cancer	0.000616	0.00794	CbGeAlD
Bumetanide—Furosemide—ALB—lung cancer	0.000531	0.396	CrCbGaD
Bumetanide—Nausea—Pemetrexed—lung cancer	0.0005	0.00238	CcSEcCtD
Bumetanide—Renal failure—Cisplatin—lung cancer	0.000499	0.00237	CcSEcCtD
Bumetanide—Nausea—Gefitinib—lung cancer	0.000496	0.00236	CcSEcCtD
Bumetanide—Thrombocytopenia—Topotecan—lung cancer	0.000494	0.00235	CcSEcCtD
Bumetanide—CA4—lymph node—lung cancer	0.000494	0.00637	CbGeAlD
Bumetanide—Thrombocytopenia—Erlotinib—lung cancer	0.000489	0.00233	CcSEcCtD
Bumetanide—Asthenia—Teniposide—lung cancer	0.000489	0.00232	CcSEcCtD
Bumetanide—PTGS2—bone marrow—lung cancer	0.000488	0.0063	CbGeAlD
Bumetanide—Hyperhidrosis—Topotecan—lung cancer	0.000488	0.00232	CcSEcCtD
Bumetanide—Pruritus—Teniposide—lung cancer	0.000482	0.00229	CcSEcCtD
Bumetanide—Vertigo—Vinorelbine—lung cancer	0.000476	0.00226	CcSEcCtD
Bumetanide—Leukopenia—Vinorelbine—lung cancer	0.000474	0.00225	CcSEcCtD
Bumetanide—Diarrhoea—Teniposide—lung cancer	0.000466	0.00222	CcSEcCtD
Bumetanide—Dehydration—Docetaxel—lung cancer	0.000466	0.00222	CcSEcCtD
Bumetanide—Hyperuricaemia—Doxorubicin—lung cancer	0.000464	0.00221	CcSEcCtD
Bumetanide—Erythema multiforme—Gemcitabine—lung cancer	0.000462	0.0022	CcSEcCtD
Bumetanide—Hyperglycaemia—Paclitaxel—lung cancer	0.000461	0.00219	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Etoposide—lung cancer	0.000461	0.00219	CcSEcCtD
Bumetanide—Renal failure—Etoposide—lung cancer	0.000457	0.00217	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Paclitaxel—lung cancer	0.000452	0.00215	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Docetaxel—lung cancer	0.000451	0.00215	CcSEcCtD
Bumetanide—Cramp muscle—Docetaxel—lung cancer	0.000451	0.00215	CcSEcCtD
Bumetanide—Arthralgia—Vinorelbine—lung cancer	0.000451	0.00214	CcSEcCtD
Bumetanide—Chest pain—Vinorelbine—lung cancer	0.000451	0.00214	CcSEcCtD
Bumetanide—Renal failure—Paclitaxel—lung cancer	0.000448	0.00213	CcSEcCtD
Bumetanide—Gynaecomastia—Methotrexate—lung cancer	0.000445	0.00212	CcSEcCtD
Bumetanide—PTGS2—lung—lung cancer	0.000443	0.0057	CbGeAlD
Bumetanide—Blood uric acid increased—Doxorubicin—lung cancer	0.000439	0.00209	CcSEcCtD
Bumetanide—Musculoskeletal pain—Doxorubicin—lung cancer	0.000436	0.00207	CcSEcCtD
Bumetanide—Fatigue—Topotecan—lung cancer	0.000435	0.00207	CcSEcCtD
Bumetanide—Vomiting—Teniposide—lung cancer	0.000433	0.00206	CcSEcCtD
Bumetanide—Hepatocellular injury—Doxorubicin—lung cancer	0.000431	0.00205	CcSEcCtD
Bumetanide—Fatigue—Erlotinib—lung cancer	0.000431	0.00205	CcSEcCtD
Bumetanide—Rash—Teniposide—lung cancer	0.00043	0.00204	CcSEcCtD
Bumetanide—Dermatitis—Teniposide—lung cancer	0.000429	0.00204	CcSEcCtD
Bumetanide—Fenoprofen—PTGS2—lung cancer	0.000428	0.319	CrCbGaD
Bumetanide—Headache—Teniposide—lung cancer	0.000427	0.00203	CcSEcCtD
Bumetanide—Gastrointestinal pain—Vinblastine—lung cancer	0.000425	0.00202	CcSEcCtD
Bumetanide—Thrombocytopenia—Vinorelbine—lung cancer	0.000423	0.00201	CcSEcCtD
Bumetanide—Muscle spasms—Irinotecan—lung cancer	0.00042	0.002	CcSEcCtD
Bumetanide—Gastrointestinal pain—Topotecan—lung cancer	0.000413	0.00196	CcSEcCtD
Bumetanide—Polyuria—Methotrexate—lung cancer	0.000411	0.00196	CcSEcCtD
Bumetanide—Abdominal pain—Vinblastine—lung cancer	0.000411	0.00195	CcSEcCtD
Bumetanide—Gastrointestinal pain—Erlotinib—lung cancer	0.000409	0.00194	CcSEcCtD
Bumetanide—Nausea—Teniposide—lung cancer	0.000405	0.00192	CcSEcCtD
Bumetanide—Hypotension—Vinorelbine—lung cancer	0.000404	0.00192	CcSEcCtD
Bumetanide—Urticaria—Topotecan—lung cancer	0.000401	0.00191	CcSEcCtD
Bumetanide—Abdominal pain—Topotecan—lung cancer	0.000399	0.0019	CcSEcCtD
Bumetanide—Abdominal pain—Erlotinib—lung cancer	0.000395	0.00188	CcSEcCtD
Bumetanide—Erythema multiforme—Etoposide—lung cancer	0.000394	0.00187	CcSEcCtD
Bumetanide—Vertigo—Irinotecan—lung cancer	0.000392	0.00186	CcSEcCtD
Bumetanide—Leukopenia—Irinotecan—lung cancer	0.000391	0.00186	CcSEcCtD
Bumetanide—Erythema multiforme—Paclitaxel—lung cancer	0.000387	0.00184	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.000383	0.00182	CcSEcCtD
Bumetanide—Fenoprofen—ALB—lung cancer	0.000381	0.284	CrCbGaD
Bumetanide—Muscle spasms—Cisplatin—lung cancer	0.000381	0.00181	CcSEcCtD
Bumetanide—Leukopenia—Gemcitabine—lung cancer	0.000381	0.00181	CcSEcCtD
Bumetanide—Renal failure—Docetaxel—lung cancer	0.00038	0.0018	CcSEcCtD
Bumetanide—Asthenia—Vinblastine—lung cancer	0.000373	0.00177	CcSEcCtD
Bumetanide—Fatigue—Vinorelbine—lung cancer	0.000372	0.00177	CcSEcCtD
Bumetanide—Asthenia—Topotecan—lung cancer	0.000362	0.00172	CcSEcCtD
Bumetanide—Arthralgia—Gemcitabine—lung cancer	0.000362	0.00172	CcSEcCtD
Bumetanide—Chest pain—Gemcitabine—lung cancer	0.000362	0.00172	CcSEcCtD
Bumetanide—Asthenia—Erlotinib—lung cancer	0.000359	0.0017	CcSEcCtD
Bumetanide—Pruritus—Topotecan—lung cancer	0.000357	0.0017	CcSEcCtD
Bumetanide—Diarrhoea—Vinblastine—lung cancer	0.000356	0.00169	CcSEcCtD
Bumetanide—Leukopenia—Cisplatin—lung cancer	0.000355	0.00169	CcSEcCtD
Bumetanide—Pruritus—Erlotinib—lung cancer	0.000354	0.00168	CcSEcCtD
Bumetanide—Gastrointestinal pain—Vinorelbine—lung cancer	0.000353	0.00168	CcSEcCtD
Bumetanide—Muscle spasms—Etoposide—lung cancer	0.000349	0.00166	CcSEcCtD
Bumetanide—Thrombocytopenia—Irinotecan—lung cancer	0.000349	0.00166	CcSEcCtD
Bumetanide—Diarrhoea—Topotecan—lung cancer	0.000346	0.00164	CcSEcCtD
Bumetanide—Hyperhidrosis—Irinotecan—lung cancer	0.000344	0.00164	CcSEcCtD
Bumetanide—Dizziness—Vinblastine—lung cancer	0.000344	0.00163	CcSEcCtD
Bumetanide—Urticaria—Vinorelbine—lung cancer	0.000343	0.00163	CcSEcCtD
Bumetanide—Muscle spasms—Paclitaxel—lung cancer	0.000342	0.00163	CcSEcCtD
Bumetanide—Diarrhoea—Erlotinib—lung cancer	0.000342	0.00163	CcSEcCtD
Bumetanide—Abdominal pain—Vinorelbine—lung cancer	0.000342	0.00162	CcSEcCtD
Bumetanide—Thrombocytopenia—Gemcitabine—lung cancer	0.00034	0.00162	CcSEcCtD
Bumetanide—Hyperhidrosis—Gemcitabine—lung cancer	0.000336	0.00159	CcSEcCtD
Bumetanide—Dizziness—Topotecan—lung cancer	0.000334	0.00159	CcSEcCtD
Bumetanide—Hypotension—Irinotecan—lung cancer	0.000333	0.00158	CcSEcCtD
Bumetanide—Vomiting—Vinblastine—lung cancer	0.000331	0.00157	CcSEcCtD
Bumetanide—Dizziness—Erlotinib—lung cancer	0.00033	0.00157	CcSEcCtD
Bumetanide—Erythema multiforme—Docetaxel—lung cancer	0.000328	0.00156	CcSEcCtD
Bumetanide—Vertigo—Etoposide—lung cancer	0.000326	0.00155	CcSEcCtD
Bumetanide—Headache—Vinblastine—lung cancer	0.000326	0.00155	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000325	0.00155	CcSEcCtD
Bumetanide—Leukopenia—Etoposide—lung cancer	0.000325	0.00155	CcSEcCtD
Bumetanide—Hypotension—Gemcitabine—lung cancer	0.000324	0.00154	CcSEcCtD
Bumetanide—Vomiting—Topotecan—lung cancer	0.000321	0.00153	CcSEcCtD
Bumetanide—Vertigo—Paclitaxel—lung cancer	0.00032	0.00152	CcSEcCtD
Bumetanide—Leukopenia—Paclitaxel—lung cancer	0.000319	0.00151	CcSEcCtD
Bumetanide—Rash—Topotecan—lung cancer	0.000318	0.00151	CcSEcCtD
Bumetanide—Dermatitis—Topotecan—lung cancer	0.000318	0.00151	CcSEcCtD
Bumetanide—Vomiting—Erlotinib—lung cancer	0.000318	0.00151	CcSEcCtD
Bumetanide—Thrombocytopenia—Cisplatin—lung cancer	0.000317	0.00151	CcSEcCtD
Bumetanide—Headache—Topotecan—lung cancer	0.000316	0.0015	CcSEcCtD
Bumetanide—Rash—Erlotinib—lung cancer	0.000315	0.0015	CcSEcCtD
Bumetanide—Dermatitis—Erlotinib—lung cancer	0.000315	0.0015	CcSEcCtD
Bumetanide—Hyponatraemia—Doxorubicin—lung cancer	0.000314	0.00149	CcSEcCtD
Bumetanide—Headache—Erlotinib—lung cancer	0.000313	0.00149	CcSEcCtD
Bumetanide—Hyperhidrosis—Cisplatin—lung cancer	0.000313	0.00149	CcSEcCtD
Bumetanide—Asthenia—Vinorelbine—lung cancer	0.00031	0.00147	CcSEcCtD
Bumetanide—Chest pain—Etoposide—lung cancer	0.000309	0.00147	CcSEcCtD
Bumetanide—Nausea—Vinblastine—lung cancer	0.000309	0.00147	CcSEcCtD
Bumetanide—Fatigue—Irinotecan—lung cancer	0.000307	0.00146	CcSEcCtD
Bumetanide—Pancreatitis—Methotrexate—lung cancer	0.000306	0.00145	CcSEcCtD
Bumetanide—Pruritus—Vinorelbine—lung cancer	0.000306	0.00145	CcSEcCtD
Bumetanide—Chest pain—Paclitaxel—lung cancer	0.000303	0.00144	CcSEcCtD
Bumetanide—Arthralgia—Paclitaxel—lung cancer	0.000303	0.00144	CcSEcCtD
Bumetanide—PTGS2—lymph node—lung cancer	0.000303	0.0039	CbGeAlD
Bumetanide—Hypotension—Cisplatin—lung cancer	0.000302	0.00144	CcSEcCtD
Bumetanide—Nausea—Topotecan—lung cancer	0.0003	0.00143	CcSEcCtD
Bumetanide—Abdominal discomfort—Methotrexate—lung cancer	0.000299	0.00142	CcSEcCtD
Bumetanide—Fatigue—Gemcitabine—lung cancer	0.000299	0.00142	CcSEcCtD
Bumetanide—Nausea—Erlotinib—lung cancer	0.000297	0.00141	CcSEcCtD
Bumetanide—Dry mouth—Paclitaxel—lung cancer	0.000296	0.00141	CcSEcCtD
Bumetanide—Diarrhoea—Vinorelbine—lung cancer	0.000296	0.00141	CcSEcCtD
Bumetanide—Blood creatinine increased—Doxorubicin—lung cancer	0.000293	0.00139	CcSEcCtD
Bumetanide—Gastrointestinal pain—Irinotecan—lung cancer	0.000291	0.00138	CcSEcCtD
Bumetanide—Dehydration—Doxorubicin—lung cancer	0.000291	0.00138	CcSEcCtD
Bumetanide—Thrombocytopenia—Etoposide—lung cancer	0.00029	0.00138	CcSEcCtD
Bumetanide—Muscle spasms—Docetaxel—lung cancer	0.00029	0.00138	CcSEcCtD
Bumetanide—Hyperhidrosis—Etoposide—lung cancer	0.000287	0.00136	CcSEcCtD
Bumetanide—Dizziness—Vinorelbine—lung cancer	0.000286	0.00136	CcSEcCtD
Bumetanide—Hypokalaemia—Doxorubicin—lung cancer	0.000285	0.00135	CcSEcCtD
Bumetanide—Thrombocytopenia—Paclitaxel—lung cancer	0.000285	0.00135	CcSEcCtD
Bumetanide—Abdominal pain—Irinotecan—lung cancer	0.000282	0.00134	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000282	0.00134	CcSEcCtD
Bumetanide—Hyperhidrosis—Paclitaxel—lung cancer	0.000281	0.00134	CcSEcCtD
Bumetanide—Hypotension—Etoposide—lung cancer	0.000277	0.00132	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000276	0.00131	CcSEcCtD
Bumetanide—Vomiting—Vinorelbine—lung cancer	0.000275	0.00131	CcSEcCtD
Bumetanide—Renal failure—Methotrexate—lung cancer	0.000274	0.0013	CcSEcCtD
Bumetanide—Rash—Vinorelbine—lung cancer	0.000272	0.00129	CcSEcCtD
Bumetanide—Dermatitis—Vinorelbine—lung cancer	0.000272	0.00129	CcSEcCtD
Bumetanide—Hypotension—Paclitaxel—lung cancer	0.000272	0.00129	CcSEcCtD
Bumetanide—Headache—Vinorelbine—lung cancer	0.000271	0.00129	CcSEcCtD
Bumetanide—Leukopenia—Docetaxel—lung cancer	0.00027	0.00128	CcSEcCtD
Bumetanide—Sweating—Methotrexate—lung cancer	0.000267	0.00127	CcSEcCtD
Bumetanide—Pancreatitis—Doxorubicin—lung cancer	0.000265	0.00126	CcSEcCtD
Bumetanide—Arthralgia—Docetaxel—lung cancer	0.000257	0.00122	CcSEcCtD
Bumetanide—Chest pain—Docetaxel—lung cancer	0.000257	0.00122	CcSEcCtD
Bumetanide—Nausea—Vinorelbine—lung cancer	0.000257	0.00122	CcSEcCtD
Bumetanide—Asthenia—Irinotecan—lung cancer	0.000256	0.00122	CcSEcCtD
Bumetanide—Fatigue—Etoposide—lung cancer	0.000256	0.00121	CcSEcCtD
Bumetanide—Dry mouth—Docetaxel—lung cancer	0.000251	0.00119	CcSEcCtD
Bumetanide—Fatigue—Paclitaxel—lung cancer	0.000251	0.00119	CcSEcCtD
Bumetanide—Asthenia—Gemcitabine—lung cancer	0.000249	0.00118	CcSEcCtD
Bumetanide—Pruritus—Gemcitabine—lung cancer	0.000246	0.00117	CcSEcCtD
Bumetanide—Hyperglycaemia—Doxorubicin—lung cancer	0.000244	0.00116	CcSEcCtD
Bumetanide—Diarrhoea—Irinotecan—lung cancer	0.000244	0.00116	CcSEcCtD
Bumetanide—Gastrointestinal pain—Etoposide—lung cancer	0.000242	0.00115	CcSEcCtD
Bumetanide—Thrombocytopenia—Docetaxel—lung cancer	0.000241	0.00115	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000239	0.00114	CcSEcCtD
Bumetanide—Gastrointestinal pain—Paclitaxel—lung cancer	0.000238	0.00113	CcSEcCtD
Bumetanide—Diarrhoea—Gemcitabine—lung cancer	0.000237	0.00113	CcSEcCtD
Bumetanide—Renal failure—Doxorubicin—lung cancer	0.000237	0.00113	CcSEcCtD
Bumetanide—Erythema multiforme—Methotrexate—lung cancer	0.000236	0.00112	CcSEcCtD
Bumetanide—Dizziness—Irinotecan—lung cancer	0.000236	0.00112	CcSEcCtD
Bumetanide—Urticaria—Etoposide—lung cancer	0.000235	0.00112	CcSEcCtD
Bumetanide—Abdominal pain—Etoposide—lung cancer	0.000234	0.00111	CcSEcCtD
Bumetanide—Asthenia—Cisplatin—lung cancer	0.000232	0.0011	CcSEcCtD
Bumetanide—Sweating—Doxorubicin—lung cancer	0.000231	0.0011	CcSEcCtD
Bumetanide—Urticaria—Paclitaxel—lung cancer	0.000231	0.0011	CcSEcCtD
Bumetanide—Hypotension—Docetaxel—lung cancer	0.00023	0.00109	CcSEcCtD
Bumetanide—Abdominal pain—Paclitaxel—lung cancer	0.00023	0.00109	CcSEcCtD
Bumetanide—Vomiting—Irinotecan—lung cancer	0.000227	0.00108	CcSEcCtD
Bumetanide—Rash—Irinotecan—lung cancer	0.000225	0.00107	CcSEcCtD
Bumetanide—Dermatitis—Irinotecan—lung cancer	0.000224	0.00107	CcSEcCtD
Bumetanide—Headache—Irinotecan—lung cancer	0.000223	0.00106	CcSEcCtD
Bumetanide—Diarrhoea—Cisplatin—lung cancer	0.000221	0.00105	CcSEcCtD
Bumetanide—Vomiting—Gemcitabine—lung cancer	0.000221	0.00105	CcSEcCtD
Bumetanide—Rash—Gemcitabine—lung cancer	0.000219	0.00104	CcSEcCtD
Bumetanide—Dermatitis—Gemcitabine—lung cancer	0.000219	0.00104	CcSEcCtD
Bumetanide—Headache—Gemcitabine—lung cancer	0.000217	0.00103	CcSEcCtD
Bumetanide—Asthenia—Etoposide—lung cancer	0.000213	0.00101	CcSEcCtD
Bumetanide—Fatigue—Docetaxel—lung cancer	0.000212	0.00101	CcSEcCtD
Bumetanide—Nausea—Irinotecan—lung cancer	0.000212	0.00101	CcSEcCtD
Bumetanide—Pruritus—Etoposide—lung cancer	0.00021	0.000997	CcSEcCtD
Bumetanide—Asthenia—Paclitaxel—lung cancer	0.000208	0.000991	CcSEcCtD
Bumetanide—Nausea—Gemcitabine—lung cancer	0.000206	0.00098	CcSEcCtD
Bumetanide—Vomiting—Cisplatin—lung cancer	0.000206	0.000978	CcSEcCtD
Bumetanide—Pruritus—Paclitaxel—lung cancer	0.000206	0.000977	CcSEcCtD
Bumetanide—Erythema multiforme—Doxorubicin—lung cancer	0.000205	0.000972	CcSEcCtD
Bumetanide—Rash—Cisplatin—lung cancer	0.000204	0.00097	CcSEcCtD
Bumetanide—Dermatitis—Cisplatin—lung cancer	0.000204	0.000969	CcSEcCtD
Bumetanide—Diarrhoea—Etoposide—lung cancer	0.000203	0.000964	CcSEcCtD
Bumetanide—Gastrointestinal pain—Docetaxel—lung cancer	0.000201	0.000957	CcSEcCtD
Bumetanide—Diarrhoea—Paclitaxel—lung cancer	0.000199	0.000945	CcSEcCtD
Bumetanide—Dizziness—Etoposide—lung cancer	0.000196	0.000932	CcSEcCtD
Bumetanide—Vertigo—Methotrexate—lung cancer	0.000195	0.000929	CcSEcCtD
Bumetanide—Abdominal pain—Docetaxel—lung cancer	0.000195	0.000926	CcSEcCtD
Bumetanide—Leukopenia—Methotrexate—lung cancer	0.000195	0.000926	CcSEcCtD
Bumetanide—Dizziness—Paclitaxel—lung cancer	0.000192	0.000913	CcSEcCtD
Bumetanide—Nausea—Cisplatin—lung cancer	0.000192	0.000913	CcSEcCtD
Bumetanide—Vomiting—Etoposide—lung cancer	0.000188	0.000896	CcSEcCtD
Bumetanide—Rash—Etoposide—lung cancer	0.000187	0.000888	CcSEcCtD
Bumetanide—Dermatitis—Etoposide—lung cancer	0.000187	0.000887	CcSEcCtD
Bumetanide—Headache—Etoposide—lung cancer	0.000186	0.000883	CcSEcCtD
Bumetanide—Arthralgia—Methotrexate—lung cancer	0.000185	0.00088	CcSEcCtD
Bumetanide—Chest pain—Methotrexate—lung cancer	0.000185	0.00088	CcSEcCtD
Bumetanide—Vomiting—Paclitaxel—lung cancer	0.000185	0.000878	CcSEcCtD
Bumetanide—Rash—Paclitaxel—lung cancer	0.000183	0.000871	CcSEcCtD
Bumetanide—Dermatitis—Paclitaxel—lung cancer	0.000183	0.00087	CcSEcCtD
Bumetanide—Headache—Paclitaxel—lung cancer	0.000182	0.000865	CcSEcCtD
Bumetanide—Muscle spasms—Doxorubicin—lung cancer	0.000181	0.000861	CcSEcCtD
Bumetanide—Asthenia—Docetaxel—lung cancer	0.000177	0.00084	CcSEcCtD
Bumetanide—Nausea—Etoposide—lung cancer	0.000176	0.000837	CcSEcCtD
Bumetanide—Pruritus—Docetaxel—lung cancer	0.000174	0.000828	CcSEcCtD
Bumetanide—Thrombocytopenia—Methotrexate—lung cancer	0.000174	0.000826	CcSEcCtD
Bumetanide—Nausea—Paclitaxel—lung cancer	0.000173	0.00082	CcSEcCtD
Bumetanide—Hyperhidrosis—Methotrexate—lung cancer	0.000172	0.000816	CcSEcCtD
Bumetanide—Vertigo—Doxorubicin—lung cancer	0.000169	0.000804	CcSEcCtD
Bumetanide—Leukopenia—Doxorubicin—lung cancer	0.000169	0.000801	CcSEcCtD
Bumetanide—Diarrhoea—Docetaxel—lung cancer	0.000169	0.000801	CcSEcCtD
Bumetanide—Hypotension—Methotrexate—lung cancer	0.000166	0.000789	CcSEcCtD
Bumetanide—Dizziness—Docetaxel—lung cancer	0.000163	0.000774	CcSEcCtD
Bumetanide—Arthralgia—Doxorubicin—lung cancer	0.00016	0.000762	CcSEcCtD
Bumetanide—Chest pain—Doxorubicin—lung cancer	0.00016	0.000762	CcSEcCtD
Bumetanide—Dry mouth—Doxorubicin—lung cancer	0.000157	0.000745	CcSEcCtD
Bumetanide—Vomiting—Docetaxel—lung cancer	0.000157	0.000744	CcSEcCtD
Bumetanide—Rash—Docetaxel—lung cancer	0.000155	0.000738	CcSEcCtD
Bumetanide—Dermatitis—Docetaxel—lung cancer	0.000155	0.000738	CcSEcCtD
Bumetanide—Headache—Docetaxel—lung cancer	0.000154	0.000733	CcSEcCtD
Bumetanide—Fatigue—Methotrexate—lung cancer	0.000153	0.000728	CcSEcCtD
Bumetanide—Thrombocytopenia—Doxorubicin—lung cancer	0.000151	0.000715	CcSEcCtD
Bumetanide—Hyperhidrosis—Doxorubicin—lung cancer	0.000149	0.000706	CcSEcCtD
Bumetanide—Nausea—Docetaxel—lung cancer	0.000146	0.000695	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methotrexate—lung cancer	0.000145	0.00069	CcSEcCtD
Bumetanide—Hypotension—Doxorubicin—lung cancer	0.000144	0.000683	CcSEcCtD
Bumetanide—Urticaria—Methotrexate—lung cancer	0.000141	0.00067	CcSEcCtD
Bumetanide—Abdominal pain—Methotrexate—lung cancer	0.00014	0.000667	CcSEcCtD
Bumetanide—Fatigue—Doxorubicin—lung cancer	0.000133	0.00063	CcSEcCtD
Bumetanide—Asthenia—Methotrexate—lung cancer	0.000127	0.000605	CcSEcCtD
Bumetanide—Gastrointestinal pain—Doxorubicin—lung cancer	0.000126	0.000598	CcSEcCtD
Bumetanide—Pruritus—Methotrexate—lung cancer	0.000126	0.000597	CcSEcCtD
Bumetanide—Urticaria—Doxorubicin—lung cancer	0.000122	0.00058	CcSEcCtD
Bumetanide—Abdominal pain—Doxorubicin—lung cancer	0.000122	0.000578	CcSEcCtD
Bumetanide—Diarrhoea—Methotrexate—lung cancer	0.000121	0.000577	CcSEcCtD
Bumetanide—Dizziness—Methotrexate—lung cancer	0.000117	0.000558	CcSEcCtD
Bumetanide—Vomiting—Methotrexate—lung cancer	0.000113	0.000537	CcSEcCtD
Bumetanide—Rash—Methotrexate—lung cancer	0.000112	0.000532	CcSEcCtD
Bumetanide—Dermatitis—Methotrexate—lung cancer	0.000112	0.000532	CcSEcCtD
Bumetanide—Headache—Methotrexate—lung cancer	0.000111	0.000529	CcSEcCtD
Bumetanide—Asthenia—Doxorubicin—lung cancer	0.00011	0.000524	CcSEcCtD
Bumetanide—Pruritus—Doxorubicin—lung cancer	0.000109	0.000517	CcSEcCtD
Bumetanide—Nausea—Methotrexate—lung cancer	0.000105	0.000501	CcSEcCtD
Bumetanide—Diarrhoea—Doxorubicin—lung cancer	0.000105	0.0005	CcSEcCtD
Bumetanide—Dizziness—Doxorubicin—lung cancer	0.000102	0.000483	CcSEcCtD
Bumetanide—Vomiting—Doxorubicin—lung cancer	9.77e-05	0.000465	CcSEcCtD
Bumetanide—Rash—Doxorubicin—lung cancer	9.69e-05	0.000461	CcSEcCtD
Bumetanide—Dermatitis—Doxorubicin—lung cancer	9.68e-05	0.00046	CcSEcCtD
Bumetanide—Headache—Doxorubicin—lung cancer	9.63e-05	0.000458	CcSEcCtD
Bumetanide—Nausea—Doxorubicin—lung cancer	9.13e-05	0.000434	CcSEcCtD
Bumetanide—CA12—Metabolism—CREBBP—lung cancer	2.75e-05	0.000178	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.74e-05	0.000177	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—RAF1—lung cancer	2.74e-05	0.000177	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SKI—lung cancer	2.73e-05	0.000176	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CAT—lung cancer	2.72e-05	0.000176	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—CREBBP—lung cancer	2.72e-05	0.000176	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.72e-05	0.000175	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOA1—lung cancer	2.71e-05	0.000175	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.71e-05	0.000175	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ADCY1—lung cancer	2.71e-05	0.000175	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ABCG2—lung cancer	2.71e-05	0.000175	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PIK3CB—lung cancer	2.69e-05	0.000174	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	2.68e-05	0.000173	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTGS2—lung cancer	2.67e-05	0.000173	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ENO2—lung cancer	2.66e-05	0.000172	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HPGDS—lung cancer	2.66e-05	0.000172	CbGpPWpGaD
Bumetanide—PTGS2—Disease—B4GALT5—lung cancer	2.65e-05	0.000171	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ABCB1—lung cancer	2.65e-05	0.000171	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP2A7—lung cancer	2.65e-05	0.000171	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPP2R1B—lung cancer	2.64e-05	0.000171	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TP53—lung cancer	2.63e-05	0.00017	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.63e-05	0.00017	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3CB—lung cancer	2.63e-05	0.00017	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.62e-05	0.000169	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.61e-05	0.000168	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CD—lung cancer	2.61e-05	0.000168	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TYMS—lung cancer	2.6e-05	0.000168	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTGS2—lung cancer	2.6e-05	0.000168	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.6e-05	0.000168	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SDC4—lung cancer	2.59e-05	0.000167	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOA1—lung cancer	2.59e-05	0.000167	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTT1—lung cancer	2.58e-05	0.000167	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTM1—lung cancer	2.57e-05	0.000166	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ALB—lung cancer	2.57e-05	0.000166	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GCLC—lung cancer	2.55e-05	0.000165	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP2A6—lung cancer	2.55e-05	0.000165	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ALB—lung cancer	2.54e-05	0.000164	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.54e-05	0.000164	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	2.5e-05	0.000162	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CG—lung cancer	2.48e-05	0.00016	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CB—lung cancer	2.45e-05	0.000158	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CB—lung cancer	2.45e-05	0.000158	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP1A1—lung cancer	2.44e-05	0.000158	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	2.43e-05	0.000157	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTGS2—lung cancer	2.43e-05	0.000157	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTGS2—lung cancer	2.43e-05	0.000157	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ERCC2—lung cancer	2.42e-05	0.000156	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ENO1—lung cancer	2.41e-05	0.000156	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.41e-05	0.000156	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—lung cancer	2.41e-05	0.000156	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.41e-05	0.000155	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.38e-05	0.000153	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PXN—lung cancer	2.37e-05	0.000153	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2.37e-05	0.000153	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CG—lung cancer	2.36e-05	0.000153	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—RRM1—lung cancer	2.36e-05	0.000153	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTA3—lung cancer	2.36e-05	0.000153	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—POMC—lung cancer	2.36e-05	0.000152	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTEN—lung cancer	2.33e-05	0.00015	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKR1C1—lung cancer	2.32e-05	0.00015	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—RAF1—lung cancer	2.3e-05	0.000149	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CREBBP—lung cancer	2.3e-05	0.000148	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CB—lung cancer	2.27e-05	0.000147	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTEN—lung cancer	2.27e-05	0.000147	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	2.27e-05	0.000147	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ALB—lung cancer	2.26e-05	0.000146	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTGS2—lung cancer	2.25e-05	0.000145	CbGpPWpGaD
Bumetanide—CA4—Metabolism—POMC—lung cancer	2.25e-05	0.000145	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	2.24e-05	0.000145	CbGpPWpGaD
Bumetanide—CA14—Metabolism—EP300—lung cancer	2.22e-05	0.000143	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—B4GALT5—lung cancer	2.22e-05	0.000143	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CREBBP—lung cancer	2.19e-05	0.000142	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	2.18e-05	0.000141	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CD—lung cancer	2.18e-05	0.000141	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP2E1—lung cancer	2.17e-05	0.00014	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—EP300—lung cancer	2.16e-05	0.00014	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTA4—lung cancer	2.16e-05	0.00014	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ALB—lung cancer	2.15e-05	0.000139	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NQO1—lung cancer	2.14e-05	0.000138	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NPPA—lung cancer	2.14e-05	0.000138	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	2.13e-05	0.000138	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	2.12e-05	0.000137	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTEN—lung cancer	2.12e-05	0.000137	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTEN—lung cancer	2.12e-05	0.000137	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.11e-05	0.000136	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTA2—lung cancer	2.1e-05	0.000136	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.1e-05	0.000136	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOA1—lung cancer	2.09e-05	0.000135	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PPIA—lung cancer	2.08e-05	0.000135	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.08e-05	0.000134	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CD—lung cancer	2.08e-05	0.000134	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ALDOA—lung cancer	2.07e-05	0.000134	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALB—lung cancer	2.05e-05	0.000133	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—RAF1—lung cancer	2.04e-05	0.000132	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTA1—lung cancer	2.03e-05	0.000131	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—EP300—lung cancer	2.02e-05	0.000131	CbGpPWpGaD
Bumetanide—CA7—Metabolism—EP300—lung cancer	2.02e-05	0.000131	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	2.01e-05	0.00013	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCC3—lung cancer	2.01e-05	0.00013	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTEN—lung cancer	1.96e-05	0.000127	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ADCY1—lung cancer	1.95e-05	0.000126	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKR1C1—lung cancer	1.94e-05	0.000126	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—STK11—lung cancer	1.93e-05	0.000125	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	1.92e-05	0.000124	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ENO2—lung cancer	1.92e-05	0.000124	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CG—lung cancer	1.91e-05	0.000123	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SMARCA4—lung cancer	1.9e-05	0.000123	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PPP2R1B—lung cancer	1.9e-05	0.000123	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CB—lung cancer	1.9e-05	0.000123	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—UGT1A1—lung cancer	1.89e-05	0.000122	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS2—lung cancer	1.88e-05	0.000122	CbGpPWpGaD
Bumetanide—CA12—Metabolism—EP300—lung cancer	1.87e-05	0.000121	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.85e-05	0.000119	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GNG11—lung cancer	1.82e-05	0.000118	CbGpPWpGaD
Bumetanide—CA9—Metabolism—POMC—lung cancer	1.82e-05	0.000117	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.81e-05	0.000117	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CB—lung cancer	1.81e-05	0.000117	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.81e-05	0.000117	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS2—lung cancer	1.79e-05	0.000116	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.79e-05	0.000116	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTP1—lung cancer	1.79e-05	0.000115	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CREBBP—lung cancer	1.77e-05	0.000114	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ENO1—lung cancer	1.74e-05	0.000113	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CAT—lung cancer	1.74e-05	0.000112	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALDOA—lung cancer	1.73e-05	0.000112	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.73e-05	0.000112	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ABCB1—lung cancer	1.69e-05	0.000109	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NCOA3—lung cancer	1.68e-05	0.000109	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CD—lung cancer	1.68e-05	0.000108	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TYMS—lung cancer	1.66e-05	0.000107	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALB—lung cancer	1.66e-05	0.000107	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.65e-05	0.000107	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PIK3CA—lung cancer	1.64e-05	0.000106	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTM1—lung cancer	1.64e-05	0.000106	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTEN—lung cancer	1.64e-05	0.000106	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ADCY1—lung cancer	1.64e-05	0.000106	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCG2—lung cancer	1.64e-05	0.000106	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APP—lung cancer	1.62e-05	0.000105	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGF9—lung cancer	1.61e-05	0.000104	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ENO2—lung cancer	1.6e-05	0.000104	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HPGDS—lung cancer	1.6e-05	0.000104	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3CA—lung cancer	1.6e-05	0.000103	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPP2R1B—lung cancer	1.59e-05	0.000103	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.57e-05	0.000102	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTEN—lung cancer	1.56e-05	0.000101	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—EP300—lung cancer	1.56e-05	0.000101	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTT1—lung cancer	1.56e-05	0.000101	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP1A1—lung cancer	1.56e-05	0.000101	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ERCC2—lung cancer	1.54e-05	9.97e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GCLC—lung cancer	1.54e-05	9.94e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP2A6—lung cancer	1.54e-05	9.94e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—JUNB—lung cancer	1.53e-05	9.91e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.53e-05	9.9e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.51e-05	9.76e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CA—lung cancer	1.49e-05	9.66e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CA—lung cancer	1.49e-05	9.66e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—EP300—lung cancer	1.49e-05	9.64e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CB—lung cancer	1.46e-05	9.46e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ENO1—lung cancer	1.46e-05	9.42e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.45e-05	9.39e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS2—lung cancer	1.45e-05	9.37e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.43e-05	9.27e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CA—lung cancer	1.38e-05	8.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FOXO3—lung cancer	1.34e-05	8.68e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—AKT1—lung cancer	1.34e-05	8.67e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOA1—lung cancer	1.34e-05	8.63e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP2E1—lung cancer	1.31e-05	8.45e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—AKT1—lung cancer	1.31e-05	8.45e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NQO1—lung cancer	1.29e-05	8.36e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.28e-05	8.26e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.27e-05	8.18e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTEN—lung cancer	1.26e-05	8.17e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—AKT1—lung cancer	1.22e-05	7.89e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—AKT1—lung cancer	1.22e-05	7.89e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CG—lung cancer	1.22e-05	7.88e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—EP300—lung cancer	1.21e-05	7.79e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HES1—lung cancer	1.19e-05	7.69e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—STK11—lung cancer	1.17e-05	7.53e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—POMC—lung cancer	1.16e-05	7.5e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CA—lung cancer	1.16e-05	7.48e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—AKT1—lung cancer	1.13e-05	7.31e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CREBBP—lung cancer	1.13e-05	7.3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ERCC2—lung cancer	1.11e-05	7.19e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CA—lung cancer	1.1e-05	7.13e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.09e-05	7.07e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ERBB3—lung cancer	1.09e-05	7.03e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTP1—lung cancer	1.08e-05	6.97e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CD—lung cancer	1.07e-05	6.92e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALB—lung cancer	1.06e-05	6.84e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CAT—lung cancer	1.05e-05	6.78e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.04e-05	6.74e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TERT—lung cancer	1.04e-05	6.74e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCB1—lung cancer	1.02e-05	6.6e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGFR1—lung cancer	1.01e-05	6.55e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TYMS—lung cancer	1e-05	6.48e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HIF1A—lung cancer	9.98e-06	6.45e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTM1—lung cancer	9.91e-06	6.41e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOA1—lung cancer	9.63e-06	6.22e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—AKT1—lung cancer	9.45e-06	6.11e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP1A1—lung cancer	9.4e-06	6.07e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CB—lung cancer	9.34e-06	6.04e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ERCC2—lung cancer	9.32e-06	6.02e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS2—lung cancer	9.25e-06	5.98e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AKT1—lung cancer	9.02e-06	5.83e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CA—lung cancer	8.92e-06	5.76e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KIT—lung cancer	8.79e-06	5.68e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APC—lung cancer	8.79e-06	5.68e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EGF—lung cancer	8.69e-06	5.61e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—BRAF—lung cancer	8.26e-06	5.34e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6R—lung cancer	8.16e-06	5.27e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CREBBP—lung cancer	8.15e-06	5.27e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTEN—lung cancer	8.07e-06	5.22e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOA1—lung cancer	8.06e-06	5.21e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MAP2K1—lung cancer	7.78e-06	5.03e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CD—lung cancer	7.73e-06	4.99e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.72e-06	4.99e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—EP300—lung cancer	7.7e-06	4.97e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CG—lung cancer	7.36e-06	4.76e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AKT1—lung cancer	7.29e-06	4.71e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—POMC—lung cancer	7.01e-06	4.53e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MDM2—lung cancer	6.92e-06	4.47e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RAF1—lung cancer	6.9e-06	4.46e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CREBBP—lung cancer	6.82e-06	4.41e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ERBB2—lung cancer	6.82e-06	4.41e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CB—lung cancer	6.73e-06	4.35e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTOR—lung cancer	6.73e-06	4.35e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD4—lung cancer	6.72e-06	4.34e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CD—lung cancer	6.47e-06	4.18e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALB—lung cancer	6.39e-06	4.13e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN1A—lung cancer	5.83e-06	3.77e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PTEN—lung cancer	5.82e-06	3.76e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CA—lung cancer	5.69e-06	3.68e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CB—lung cancer	5.64e-06	3.64e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EP300—lung cancer	5.55e-06	3.59e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SRC—lung cancer	5.4e-06	3.49e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STAT3—lung cancer	5.2e-06	3.36e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NRAS—lung cancer	5.19e-06	3.36e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MAPK3—lung cancer	4.97e-06	3.21e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PTEN—lung cancer	4.87e-06	3.15e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MYC—lung cancer	4.84e-06	3.13e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EGFR—lung cancer	4.73e-06	3.06e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AKT1—lung cancer	4.65e-06	3.01e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—EP300—lung cancer	4.65e-06	3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KRAS—lung cancer	4.47e-06	2.89e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CA—lung cancer	4.11e-06	2.65e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HRAS—lung cancer	3.8e-06	2.45e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—lung cancer	3.64e-06	2.35e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CA—lung cancer	3.44e-06	2.22e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKT1—lung cancer	3.35e-06	2.17e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKT1—lung cancer	2.81e-06	1.82e-05	CbGpPWpGaD
